Gaps in cardiovascular disease risk management in Australian general practice

Medical Journal of Australia

Volumn 191, Issue 6, 2009, Pages 324-329

  Webster, Ruth J ^a   Heeley, Emma L ^a   Peiris, David P ^a   Bayram, Clare ^b   Cass, Alan ^a,c   Patel, Anushka A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN;

ARTICLE; AUSTRALIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; PRESCRIPTION; RISK MANAGEMENT;

EID: 77951128294     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02816.x     Document Type: Article

References (27)

1. Australian Institute of Health and Welfare. Australia's health 2008. Canberra: AIHW, 2008. (AIHW Cat. No. AUS 99.)
2. Knox SA, Harrison CM, Britt HC, Henderson JV. Estimating prevalence of common chronic morbidities in Australia. Med J Aust 2008; 189: 66-70.
3. Jackson R, Lawes CM, Bennett DA, et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005; 365: 434-441. (Pubitemid 40179232)
4. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293-298.
5. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. BMJ 2000; 320: 705-708.
6. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000; 320: 709-710. (Pubitemid 30179401)
7. National Heart Foundation of Australia. Hypertension management guide for doctors, 2004. Canberra: NHF, 2003.
8. Tonkin A, Barter P, Best J, et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management - 2005. Heart Lung Circ 2005; 14: 275-291.
9. Harris P, Mann L, Phillips P, et al. Diabetes management in general practice. 11th ed, 2005/6. Norah Head: Diabetes Australia and Royal Australian College of General Practitioners, 2005.
10. Jackson R, Lynch J, Harper S. Preventing coronary heart disease. BMJ 2006; 332: 617-618.
11. Britt H, Miller GC, Charles J, et al. General practice activity in Australia 2006-2007. Canberra: Australian Institute of Health and Welfare, 2008. (AIHW Cat. No. GEP 21.)
12. Britt H, Miller G, Bayram C. The quality of data on general practice - a discussion of BEACH reliability and validity. Aust Fam Physician 2007; 36: 36-40.
13. Britt H, Miller GC, Henderson J, Bayram C. Patient-based substudies from BEACH: abstracts and research tools 1999-2006. Canberra: Australian Institute of Health and Welfare, 2007. (AIHW Cat. No. GEP 20.)
14. Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 6th ed. Melbourne: RACGP, 2005.
15. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Reducing risk in heart disease 2004: guidelines for preventing cardiovascular events in people with coronary heart disease. Canberra: NHF, 2004.
16. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Lipid management guidelines - 2001. Med J Aust 2001; 175 (9 Suppl): S57-S88.
17. National Stroke Foundation. Clinical guidelines for stroke rehabilitation and recovery. Melbourne: NSF, 2005.
18. Britt H, Miller G, Charles J, et al. General practice activity in Australia 2005-2006. Canberra: Australian Institute of Health and Welfare, 2007. (AIHW Cat. No. GEP 19.)
19. National Blood Pressure and Vascular Disease Advisory Committee, National Heart Foundation of Australia. Guide to management of hypertension 2008. Canberra: NHF, 2008.
20. Vale MJ, Jelinek MV, Best JD; on behalf of the COACH study group. How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000. Med J Aust 2002; 176: 211-215.
21. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Reducing risk in heart disease 2007: guidelines for preventing cardiovascular events in people with coronary heart disease. Canberra: NHF, 2008.
22. Smith SC Jr, Allen J, Blair SN, et al; AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363-2372. (Pubitemid 43947981)
23. Peeters A, Ting J, Nelson MR, McNeil JJ. Coronary heart disease risk prediction by general practitioners in Victoria [letter]. Med J Aust 2004; 180: 252. (Pubitemid 38312992)
24. Montgomery AA, Fahey T, MacKintosh C, et al. Estimation of cardiovascular risk in hypertensive patients in primary care. Br J Gen Pract 2000; 50: 127-128. (Pubitemid 30076681)
25. Forge BH, Briganti EM. Lipid lowering and coronary heart disease risk: how appropriate are the national guidelines? Med J Aust 2001; 175: 471-475. (Pubitemid 33039858)
26. Chen L, Rogers SL, Colagiuri S, et al. How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000. Med J Aust 2008; 189: 319-322.
27. National Health and Medical Research Council. A guide to the development, evaluation and implementation of clinical practice guidelines. Canberra: NHMRC, 1999.